Completed Pilot Trial Tests CGM Plus Telehealth for Underserved Type 2 Diabetes Patients — Early Results Show Promise for FQHC Care Models

References

1. 1.University of Illinois at Chicago. (2024). The Role of Remote Pharmacy Services With Continuous Glucose Monitoring in an Underserved Population. ClinicalTrials.gov. https://clinicaltrials.gov/study/NCT07587151
2. 2.Hill-Briggs, F., Adler, N. E., Berkowitz, S. A., Chin, M. H., Gary-Webb, T. L., Navas-Acien, A., Thornton, P. L., & Haire-Joshu, D. (2021). Social determinants of health and diabetes: A scientific statement from the American Diabetes Association. Diabetes Care, 44(1), 258-279. https://doi.org/10.2337/dci20-0053
3. 3.ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., Kahan, S., Khunti, K., Leon, J., Lyons, S. K., Perry, M. L., Prahalad, P., Pratley, R. E., Seley, J. J., Stanton, R. C., ... Gabbay, R. A. (2023). Standards of Care in Diabetes—2023. Diabetes Care, 46(Supplement_1), S1-S291. https://doi.org/10.2337/dc23-S001
4. 4.Patel, M., Sheehan, J., & Vigil, G. (2022). Continuous glucose monitoring in federally qualified health centers: A systematic review. Journal of Community Health, 47(3), 456-467. https://doi.org/10.1007/s10900-022-01089-4
5. 5.Walker, R. J., Smalls, B. L., Campbell, J. A., Strom Williams, J. L., & Egede, L. E. (2020). Impact of social determinants of health on outcomes for type 2 diabetes: A systematic review. Endocrine, 67(1), 51-63. https://doi.org/10.1007/s12020-020-02216-6
6. 6.National Association of Community Health Centers. (2023). America's Health Centers: 2022 Snapshot. https://www.nachc.org/research-and-data/americas-health-centers/
7. 7.Danne, T., Nimri, R., Battelino, T., Bergenstal, R. M., Close, K. L., DeVries, J. H., Garg, S., Heinemann, L., Hirsch, I., Amiel, S. A., Beck, R., Bosi, E., Buckingham, B., Cobelli, C., Dassau, E., Doyle, F. J., Heller, S., Hovorka, R., Jia, W., ... Phillip, M. (2017). International consensus on use of continuous glucose monitoring. Diabetes Care, 40(12), 1631-1640. https://doi.org/10.2337/dc17-1600
8. 8.Australian Government Department of Health. (2024). Pharmaceutical Benefits Scheme: Continuous Glucose Monitoring. https://www.pbs.gov.au/medicine/item/12687E